FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a solid oral pharmaceutical formulation containing a hydrolised form of 5-chloro-M-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide in the amount of 1 to 60%. The formulation contains sodium lauryl sulphate as a wetting agent and hydroxypropylmethyl cellulose as a hydrophilic binding agent. The pharmaceutical formulation is presented in the form of a tablet.
EFFECT: formulation according to the invention provides higher biological availability of the active ingredient.
17 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MAKING SOLID ORAL PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2379036C2 |
| HARD, SUITABLE FOR ORAL INTAKE PHARMACEUTICAL FORMS OF APPLICATION, CONTAINING RIVAROXABAN WITH MODIFIED RELEASE | 2005 |
|
RU2420290C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| SOLID MEDICINAL FORM FOR ORAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE SUBSTANCES SHOWING UNFAVORABLE ORGANOLEPTIC PROPERTIES | 1991 |
|
RU2085190C1 |
| NIMESULIDE-CONTAINING SUSTAINED-RELEASE COMPOSITIONS | 2000 |
|
RU2238087C2 |
| ORAL SOLID PHARMACEUTICAL FORMS WITH FAST RELEASE ACTIVE SUBSTANCE | 2006 |
|
RU2440119C2 |
| NOVEL COMPOSITION CONTAINING ACID-NONSTABLE OMEPRAZOLE AND METHOD OF ITS PREPARING | 1996 |
|
RU2161481C2 |
| COMPOSITIONS CONTAINING FINELY GROUND NEBIVOLOL | 1995 |
|
RU2137473C1 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIMICROBIAL ACTION, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497501C1 |
